{
    "Trade/Device Name(s)": [
        "HbA1c Linearity Set",
        "Cone Bioproducts HbA1c Linearity Set",
        "Hemoglobin A1c Linearity Set"
    ],
    "Submitter Information": "Cone Bioproducts",
    "510(k) Number": "k052010",
    "Predicate Device Reference 510(k) Number(s)": [
        "k040535"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "October 4, 2005",
    "Summary Letter Received Date": "September 16, 2005",
    "Submission Date": "September 1, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c (HbA1c%)"
    ],
    "Specimen Type(s)": [
        "Human Blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunoassay",
        "HPLC"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Cone Bioproducts HbA1c Linearity Set as a quality control material to demonstrate linearity of Hemoglobin A1c for immunoassay and HPLC methods",
    "Indications for Use Summary": "Intended for use as quality control material to demonstrate linearity throughout the reportable range of Hemoglobin A1c (HbA1c%) for immunoassay and HPLC test methods using laboratory protocols",
    "fda_folder": "Clinical Chemistry"
}